Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
This study has been completed.
Study NCT00167999   Information provided by Wyeth
First Received: September 11, 2005   Last Updated: March 14, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gram-Positive Bacterial Infections
Escherichia Coli Infections
Klebsiella Infections
Additional conditions recognized in this trial
Bacterial Infections
Communicable Diseases
Infection
More general conditions related to this trial
Enterobacteriaceae Infections
Gram-Negative Bacterial Infections
Interventions listed in this trial
piperacillin-tazobactam
Additional drug interventions recognized in this trial
Penicillanic Acid
Piperacillin
Piperacillin-tazobactam combination product
Tazobactam
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Wyeth


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services